Monte Rosa CEO Sells $141K in Stock Amid 300% Surge and Recent Capital Raise
Monte Rosa Therapeutics (GLUE) CEO Markus Warmuth sold 8,000 shares of common stock for $141,000 on April 14, 2026, reducing his direct holdings by 1.30%. The sale occurred amid a 300% stock surge and a recent capital raise. The transaction was reported in an SEC Form 4 filing.
Tickers: $GLUE
Topics: corporate governance executive stock sales SEC filings stock market activity